Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|January 31, 2015
Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitorsCynthia A Morgan, Thomas D Hurley
Chemico-Biological Interactions|December 3, 2014
Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1Cynthia A Morgan, Thomas D Hurley
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonistsRuth A Duffy, Geoffrey B Varty, Cynthia A Morgan, et al.
Chemico-Biological Interactions|December 17, 2014
N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymesCynthia A Morgan, Bibek Parajuli, Cameron D Buchman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2002
The gerbil elevated plus-maze I: behavioral characterization and pharmacological validationGeoffrey B Varty, Cynthia A Morgan, Mary E Cohen-Williams, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2002
The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonistsGeoffrey B Varty, Mary E Cohen-Williams, Cynthia A Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Cyclobutane derivatives as potent NK1 selective antagonistsMichelle Laci Wrobleski, Gregory A Reichard, Sunil Paliwal, et al.
Journal of Medicinal Chemistry|March 6, 2020
Discovery and Development of Small-Molecule Inhibitors of Glycogen SynthaseBuyun Tang, Mykhaylo S Frasinyuk, Vimbai M Chikwana, et al.
Journal of Medicinal Chemistry|September 18, 2018
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer ChemotherapyBrandt C Huddle, Edward Grimley, Cameron D Buchman, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2008
The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)Geoffrey B Varty, Sherry X Lu, Cynthia A Morgan, et al.
Pageof 2